Skip to main content
RESEARCH GROUPS

Dynamic Biomimetics for Cancer Immunotherapy (DBCI)

Bioinspired materials, artificial extracellular matrices, patient-derived cancer organoids and cellular manufacturing approaches for advanced cancer immunotherapy research.

Research Focus
Group Website
People

Bioinspired materials for cancer immunotherapy research

The Dynamic Biomimetics for Cancer Immunotherapy (DBCI) group explores how bioinspired materials can help reproduce, interrogate and influence complex biological environments relevant to cancer immunotherapy.

The group started as a Max Planck Partner Group in 2017 funded by the Max Planck Society in Germany, and currently focuses on the design, synthesis and fabrication of biomimetic materials for biomedical applications.

Its research is especially oriented towards the oncology field, including artificial extracellular matrices, patient-derived cancer organoids and new methodologies related to cellular manufacturing processes for cancer immunotherapies.

Research focus

DBCI connects materials science, biomimetic design and cancer biology to develop advanced platforms for understanding and supporting immunotherapy-related research.

Materials design

Bioinspired materials

Design, synthesis and fabrication of biomimetic materials for biomedical applications.
Biomimetic platforms

Artificial extracellular matrices

Dynamic material environments inspired by biological matrices and cellular interactions.
Oncology models

Cancer organoids

Patient-derived cancer organoid platforms for advanced biomedical and translational research.
Immunotherapy processes

Cellular manufacturing

New methodologies related to cellular manufacturing processes for cancer immunotherapies.

Materials, biology and immunotherapy-oriented platforms

DBCI works at the interface between advanced materials research and biomedical science. The group uses biomimetic concepts to create material systems that can reproduce key features of biological environments and support more relevant experimental models for cancer research.

The approach combines materials design, bioinspired fabrication, cellular models and oncology-oriented methodologies to contribute to the development of future immunotherapy research platforms.

Visit DBCI Website
Concept

Dynamic biomimetics

Materials systems designed to emulate dynamic biological structures and cellular environments.
Application

Biomedical materials

Bioinspired materials for experimental platforms in oncology and immunotherapy research.
Models

Organoid environments

Patient-derived cancer organoid methodologies connected to materials-based microenvironments.
Impact

Translational interface

A bridge between fundamental materials science, biomedical models and cancer immunotherapy innovation.

People

Researchers associated with the Dynamic Biomimetics for Cancer Immunotherapy group.

Permanent Scientific Researchers

Postdoctoral & Project Researchers

Connected to the ICMAB research ecosystem

DBCI contributes to ICMAB’s materials-for-health ecosystem by connecting biomimetic materials, biomedical models and cancer immunotherapy-oriented research.

Research ecosystem

Research Groups

Explore the full map of ICMAB materials science research teams.
Scientific structure

Research Units

Discover research units connecting groups, expertise and scientific challenges.
Strategic line

Materials for Health

Explore ICMAB research on bioactive materials, nanomedicine, theranostics and biomedical technologies.

Contact and group website

For detailed information about DBCI research activity, current projects, publications and opportunities, visit the external group website or contact the group through the corresponding ICMAB channels.

Visit DBCI Website
Research Groups Overview

Dynamic Biomimetics for Cancer Immunotherapy

Bioinspired materials, artificial extracellular matrices, patient-derived cancer organoids and cellular manufacturing processes for cancer immunotherapies.